Long-term business growth through the acquisition of voting rights in SENSIMED AG
First written in FY2020-Q3. 6 of 11 entries say "Advanced", first in FY2020. Latest entry: 2026-08-26.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「At a meeting of the Board of Directors held on 19 May 2026, we resolved that the smart contact lens business would change from the Company to オキュデバイセズ, which we newly established with 100% funding on 15 May 2026 through a company split.」
The smart contact lens business changed from the Company to the newly established subsidiary オキュデバイセズ effective 1 July 2026, marking the stage of accelerating open business operations and collaboration with research and development partners in anticipation of capital and business alliances. - FY2026-H1AdvancedAnnual report
「In February 2025, we launched an advanced general-purpose platform for electronic-device-integrated contact lenses, or smart contact lenses, and are inviting ideas and proposals for joint development from advanced technology companies and research institutions worldwide.」
We released electronic component integration and general-purpose drive technologies for smart contact lenses as a platform and progressed to soliciting joint development proposals from external companies and research institutions. - FY2025AdvancedAnnual report
「The company has successfully standardized the technology for integrating various electronic components, including antennas and semiconductor chips, as well as large-scale integrated circuits, into contact lenses, and developed large-scale integrated circuits capable of generally driving a wide range of devices. It has converted this technology into a platform and disclosed it publicly.」
In the smart contact lens field, including Sensimed, we successfully developed electronic component integration and general-purpose drive technologies and proceeded to announce the platform. - FY2020AdvancedAnnual report
「Sensimed AG develops, manufactures and sells the Triggerfish System, a medical contact lens that we began selling commercially in December 2018. By acquiring control of the company, we aim to strengthen our international position in the smart contact lens field and achieve medium- to long-term growth.」
On 24 December 2019, we completed the conversion of Sensimed AG into a subsidiary, with a 90.69% voting interest, for the purpose of achieving medium- to long-term growth in the smart contact lens field. - FY2020-Q3First statedAnnual report
「From the perspective of long-term business growth, increased the number of voting rights held to 90.6% of the company’s issued shares by acquiring shares from existing shareholders in December 2019」
Regarding SENSIMED AG, this is the first explicit statement of measures to increase the number of voting rights held to 90.6% through the acquisition of shares from existing shareholders, while recognizing impairment losses on investments and loans.